These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity. Huai Q; Liu Y; Francis SH; Corbin JD; Ke H J Biol Chem; 2004 Mar; 279(13):13095-101. PubMed ID: 14668322 [TBL] [Abstract][Full Text] [Related]
9. Identification of a brain penetrant PDE9A inhibitor utilizing prospective design and chemical enablement as a rapid lead optimization strategy. Verhoest PR; Proulx-Lafrance C; Corman M; Chenard L; Helal CJ; Hou X; Kleiman R; Liu S; Marr E; Menniti FS; Schmidt CJ; Vanase-Frawley M; Schmidt AW; Williams RD; Nelson FR; Fonseca KR; Liras S J Med Chem; 2009 Dec; 52(24):7946-9. PubMed ID: 19919087 [TBL] [Abstract][Full Text] [Related]
10. Searching for a reliable orientation of ligands in their binding site: comparison between a structure-based (Glide) and a ligand-based (FIGO) approach in the case study of PDE4 inhibitors. Gratteri P; Bonaccini C; Melani F J Med Chem; 2005 Mar; 48(5):1657-65. PubMed ID: 15743207 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the relationship between protein-protein interaction and catalytic activity of a heme-regulated phosphodiesterase from Escherichia coli (Ec DOS) by protein microarray. Sasakura Y; Kanda K; Yoshimura-Suzuki T; Matsui T; Fukuzono S; Shimizu T Biochemistry; 2005 Jul; 44(28):9598-605. PubMed ID: 16008345 [TBL] [Abstract][Full Text] [Related]
12. Seven Dictyostelium discoideum phosphodiesterases degrade three pools of cAMP and cGMP. Bader S; Kortholt A; Van Haastert PJ Biochem J; 2007 Feb; 402(1):153-61. PubMed ID: 17040207 [TBL] [Abstract][Full Text] [Related]
13. The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents. Deninno MP; Andrews M; Bell AS; Chen Y; Eller-Zarbo C; Eshelby N; Etienne JB; Moore DE; Palmer MJ; Visser MS; Yu LJ; Zavadoski WJ; Michael Gibbs E Bioorg Med Chem Lett; 2009 May; 19(9):2537-41. PubMed ID: 19339180 [TBL] [Abstract][Full Text] [Related]
14. Renaturation of the catalytic domain of PDE4A expressed in Escherichia coli as inclusion bodies. Richter W; Hermsdorf T; Dettmer D Methods Mol Biol; 2005; 307():155-65. PubMed ID: 15988062 [TBL] [Abstract][Full Text] [Related]
15. The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis. Huai Q; Colicelli J; Ke H Biochemistry; 2003 Nov; 42(45):13220-6. PubMed ID: 14609333 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a catalytic ligand bridging metal ions in phosphodiesterases 4 and 5 by molecular dynamics simulations and hybrid quantum mechanical/molecular mechanical calculations. Xiong Y; Lu HT; Li Y; Yang GF; Zhan CG Biophys J; 2006 Sep; 91(5):1858-67. PubMed ID: 16912214 [TBL] [Abstract][Full Text] [Related]
17. A newly identified 50 kDa protein, which is associated with phosphodiesterase 3B, is phosphorylated by insulin in rat adipocytes. Onuma H; Osawa H; Ogura T; Tanabe F; Nishida W; Makino H Biochem Biophys Res Commun; 2005 Nov; 337(3):976-82. PubMed ID: 16225849 [TBL] [Abstract][Full Text] [Related]
18. Signaling at crossroads: the dialogue between PDEs and PKA is spoken in multiple languages. Moleschi K; Melacini G Biophys J; 2014 Sep; 107(6):1259-60. PubMed ID: 25229132 [No Abstract] [Full Text] [Related]
19. Determining the subunit structure of phosphodiesterases using gel filtration and sucrose density gradient centrifugation. Richter W Methods Mol Biol; 2005; 307():167-80. PubMed ID: 15988063 [TBL] [Abstract][Full Text] [Related]